These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1803369)

  • 21. [Histopathomorphosis of tuberculous lesions in the lungs in the course of chronic tuberculosis treated with antituberculous drugs].
    Szymańska D
    Patol Pol; 1972; 23(3):351-62. PubMed ID: 5072526
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
    J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side effects of short course tuberculosis chemotherapy.
    Simon GK; Lye MS; Ahmad N
    Med J Malaysia; 1991 Mar; 46(1):88-94. PubMed ID: 1836044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV; Ovsiankina ES
    Probl Tuberk; 2003; (1):28-30. PubMed ID: 12652980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The problem of drug allergy in patients with tuberculosis].
    Pukhlik BM; Mzaĭek V; Zaĭkov SV
    Probl Tuberk; 1990; (11):29-30. PubMed ID: 2290810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
    Kazakov KS; Zakharova RI; Absadykova FT
    Probl Tuberk; 1990; (9):40-2. PubMed ID: 2274509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)].
    Eule H; Iwainsky H
    Prax Klin Pneumol; 1981 Aug; 35(8):347-53. PubMed ID: 7345430
    [No Abstract]   [Full Text] [Related]  

  • 30. [Action of tuberculostatics on the gastric mucosa].
    Novaes Hde M; Soares EC; Moura AC; Cordoni Júnior L; de Jesus MM
    AMB Rev Assoc Med Bras; 1972 Jul; 18(7):251-4. PubMed ID: 4538785
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].
    Karachunskiĭ MA; Kaminskaia GO; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (9):25-8. PubMed ID: 15532463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 33. [Measurement of the chemiluminescence of the urine and blood serum during the adverse effects of drugs on patients with tuberculosis].
    Shchutskaia EI; Priakhina VN; Kolpakova TA
    Probl Tuberk; 1989; (1):55-9. PubMed ID: 2717593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functions of the gastric mucosa and the pancreas under the influence of antitubercular agents].
    Schilling W
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):274-9. PubMed ID: 5755198
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM; Smolenko MI; Romaniuk MD; Slivka IuI
    Probl Tuberk; 1990; (11):25-8. PubMed ID: 2290809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Side effects of chemotherapy in patients with tuberculosis and methods of their elimination].
    Shevchenko VV; Biazrov TA; Vasina IN
    Probl Tuberk; 1969; 47(2):45-9. PubMed ID: 5380563
    [No Abstract]   [Full Text] [Related]  

  • 37. [Side effects in antibacterial therapy of patients with pulmonary tuberculosis based on dispensary data].
    Simonian LK
    Probl Tuberk; 1969; 47(1):18-22. PubMed ID: 5380201
    [No Abstract]   [Full Text] [Related]  

  • 38. [Follow-up of antitubercular treatment].
    Gavira R; Gómez F; Otero MJ; Barrueco M; Domínguez-Gil A
    Rev Clin Esp; 1994 Sep; 194(9):677-81. PubMed ID: 7984795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jaundice due to anti-tuberculous drugs--a dose related phenomenon.
    Mirchandani LV; Joshi JM
    J Assoc Physicians India; 1995 Nov; 43(11):767-9. PubMed ID: 8773037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of the treatment using pyrazinamide, ethioniamide and other drugs. Histoenzymological study on liver biopsies].
    Tarallo NH; Acosta-Ferreira W; Reissenweber NJ; Appeltauer LC; Sicardi R
    Hoja Tisiol; 1967; 24(1):104-22. PubMed ID: 4896550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.